HCRTR1 |
HCRTR1: Orexin receptor type 1 |
GNAO1 |
GNAO1: Guanine nucleotide-binding protein G(o) subunit alpha 1 |
0.265 |
Evidence |
|
TNFSF9 |
TNFSF9: Tumor necrosis factor ligand superfamily member 9 |
TNFRSF18 |
TNFRSF18, AITR, UNQ319/PRO364, GITR: Tumor necrosis factor receptor superfamily |
0.265 |
Evidence |
|
GPR78 |
GPR78, UNQ5925/PRO19818: Probable G-protein coupled receptor 78 |
GNAI2 |
Galphai2 protein |
0.265 |
Evidence |
|
KCNA6 |
KCNA6: Potassium voltage-gated channel subfamily A member 6 |
KCNG3 |
KCNG3: Potassium voltage-gated channel subfamily G member 3 |
0.265 |
Evidence |
|
ID3 |
ID3, 1R21, HEIR-1: DNA-binding protein inhibitor ID-3 |
NEUROD2 |
NEUROD2, NDRF: Neurogenic differentiation factor 2 |
0.265 |
Evidence |
|
GLRA3 |
GLRA3: Glycine receptor subunit alpha-3 precursor |
GABRR1 |
IPI00027150 |
0.265 |
Evidence |
|
GNA11 |
GNA11, GA11: Guanine nucleotide-binding protein subunit alpha-11 |
OXGR1 |
OXGR1, GPR80, GPR99, P2RY15, P2Y15: 2-oxoglutarate receptor 1 |
0.265 |
Evidence |
|
NALP13 |
NLRP13, NALP13, NOD14: NACHT, LRR and PYD domains-containing protein 13 |
TEP1 |
TEP1, TLP1, TP1: Telomerase protein component 1 |
0.265 |
Evidence |
|
GNAI3 |
GNAI3: Guanine nucleotide-binding protein G(k) subunit alpha |
MCHR2 |
MCHR2, GPR145, SLT: Melanin-concentrating hormone receptor 2 |
0.265 |
Evidence |
|
BAX |
BAX: BAX protein, cytoplasmic isoform delta |
BAX |
BAX: Apoptosis regulator BAX, cytoplasmic isoform beta |
0.265 |
Evidence |
|
MASP2 |
MASP2: Mannan-binding lectin serine protease 2 precursor |
SERPINB10 |
SERPINB10, PI10: Serpin B10 |
0.265 |
Evidence |
|
KCNH6 |
KCNH6, ERG2, HERG2: Potassium voltage-gated channel subfamily H member 6 |
TRPC7 |
TRPC7, TRP7: Short transient receptor potential channel 7 |
0.265 |
Evidence |
|
GNAZ |
GNAZ: Guanine nucleotide-binding protein G(z) subunit alpha |
UTS2R |
UTS2R, GPR14: Urotensin II receptor |
0.265 |
Evidence |
|
BAX |
BAX: Apoptosis regulator BAX, membrane isoform alpha |
BCL2L13 |
BCL2L13, MIL1, CD003: Bcl-2-like 13 protein |
0.265 |
Evidence |
|
RGS11 |
IPI00015558 |
WDR5 |
WDR5, BIG3: WD repeat-containing protein 5 |
0.265 |
Evidence |
|
GNA15 |
GNA15, GNA16: Guanine nucleotide-binding protein alpha-15 subunit |
UTS2R |
UTS2R, GPR14: Urotensin II receptor |
0.265 |
Evidence |
|
OLIG1 |
OLIG1: Oligodendrocyte transcription factor 1 |
ASCL2 |
ASCL2: Achaete-scute homolog 2 |
0.265 |
Evidence |
|
GNAO1 |
GNAO1: Guanine nucleotide-binding protein G(o) subunit alpha 1 |
GPR78 |
GPR78, UNQ5925/PRO19818: Probable G-protein coupled receptor 78 |
0.265 |
Evidence |
|
GNAS |
GNAS, GNAS1, GSP: Guanine nucleotide-binding protein G(s) subunit alpha isoforms |
OR5P3 |
OR5P3: Olfactory receptor 5P3 |
0.265 |
Evidence |
|
ABCD4 |
ABCD4, PXMP1L: ATP-binding cassette sub-family D member 4 |
ABCC9 |
ABCC9, SUR2: ATP-binding cassette transporter sub-family C member 9 |
0.265 |
Evidence |
|
KCNH7 |
KCNH7, ERG3: Potassium voltage-gated channel subfamily H member 7 |
CNGB1 |
RCNC2: Rod photoreceptor CNG-channel beta subunit |
0.265 |
Evidence |
|
MYF6 |
MYF6: Myogenic factor 6 |
OLIG1 |
OLIG1: Oligodendrocyte transcription factor 1 |
0.265 |
Evidence |
|
GNA13 |
GNA13: Guanine nucleotide-binding protein alpha-13 subunit |
GPR81 |
GPR81, GPR104, FKSG80: Probable G-protein coupled receptor 81 |
0.265 |
Evidence |
|
BCL10 |
BCL10, CIPER, CLAP: B-cell lymphoma/leukemia 10 |
TEP1 |
TEP1, TLP1, TP1: Telomerase protein component 1 |
0.265 |
Evidence |
|
NOS2A |
NOS2A, NOS2: Nitric oxide synthase, inducible |
CYP21A2 |
CYP21A2, CYP21, CYP21B: Cytochrome P450 21 |
0.265 |
Evidence |
|